Directori de persones
Sonia Gatius Caldero

Sonia Gatius Caldero

Grau: Doctor/a

973 705312
sgatius.lleida.ics(ELIMINAR)@gencat.cat

Grups

Publicacions

  • Gatius S; Jove M; Megino-Luque C; Albertí-Valls M; Yeramian A; Bonifaci N; Piñol M; Santacana M; Pradas I; Llobet-Navas D; Pamplona R; Matías-Guiu X; Eritja N

    Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer.

    Cancers 14 -. .

    [doi:10.3390/cancers14122842]

  • Megino-Luque, Cristina; Siso, Pol; Mota-Martorell, Natalia; Navaridas, Raul; de la Rosa I; Urdanibia, Izaskun; Alberti-Valls, Manel; Santacana, Maria; Pinyol, Miquel; Bonifaci, Nuria; Macia, Anna; Llobet-Navas, David; Gatius, Sonia; Matias-Guiu, Xavier; Eritja, Nuria

    ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma.

    MOLECULAR ONCOLOGY 16 2235-2259. .

    [doi:10.1002/1878-0261.13193]

  • Gatius, S; Velasco, A; Varela, M; Cuatrecasas, M; Jares, P; Setaffy, L; Bonhomme, B; Santon, A; Lindemann, K; Croce, S; Davidson, B; Lax, S; Palacios, J; Matias-Guiu, X

    Comparison of the Idylla™ MSI assay with the Promega™ MSI Analysis System and immunohistochemistry on formalin-fixed paraffin-embedded tissue of endometrial carcinoma: results from an international, multicenter study.

    VIRCHOWS ARCHIV 480 1031-1039. .

    [doi:10.1007/s00428-022-03291-x]

  • Mota, A; Oltra, SS; Selenica, P; Moiola, CP; Casas-Arozamena, C; Lopez-Gil, C; Diaz, E; Gatius, S; Ruiz-Miro, M; Calvo, A; Rojo-Sebastian, A; Hurtado, P; Piñeiro R; Colas, E; Gil-Moreno, A; Reis-Filho, JS; Muinelo-Romay, L; Abal, M; Matias-Guiu, X; Weigelt, B; Moreno-Bueno, G

    Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression.

    ONCOGENE 41 1835-1850. .

    [doi:10.1038/s41388-022-02221-0]

  • MORENO, S; MAIQUES, O; Romero M; Santacana M; Gómez I; Cuevas D; Velasco A; Veà À; Macià A; Barceló C; BOIX, R; VALLS, J; GATIUS, S; CANTI, C; MATIAS-GUIU, X; SORIA, X; MARTI, RM

    Differential Immunoexpression of BRAF/V600E, Senescence Markers, PTEN, and T-type Calcium Channels in Acquired Naevi According to their Histopathological and Dermoscopic Classification.

    ACTA DERMATO-VENEREOLOGICA 101 -. .

    [doi:10.2340/actadv.v101.361]

  • Soria X; Vilardell F; Maiques Ó; Barceló C; Sisó P; de la Rosa I; Velasco A; Cuevas D; Santacana M; Gatius S; Matías-Guiu X; Rodrigo A; Macià A; Martí RM

    BRAF(V600E)

    Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics

    Cancers 13 -. .

    [doi:10.3390/cancers13205073]

  • Manning-Geist BL; Gatius S; Liu Y; Gil M; Da Cruz Paula A; Tuset N; Abu-Rustum NR; Aghajanian C; Weigelt B; Matias-Guiu X

    Diagnosis and management of an endometrial cancer patient with Cowden syndrome.

    GYNECOLOGIC ONCOLOGY 163 14-21. .

    [doi:10.1016/j.ygyno.2021.08.008]

  • Ojanguren A; Santamaría M; Milla-Collado L; Fraile C; Gatius-Calderó S; Puy S; Boldó A; Gómez-Olles S; Boada-Pérez M; Esquinas C; Sáez-Giménez B; Ojanguren I; Barrecheguren M; Olsina-Kissler JJ

    Pilot Trial of Extended Hypothermic Lung Preservation to Analyze Ischemia-reperfusion Injury in Pigs.

    ARCHIVOS DE BRONCONEUMOLOGIA 57 479-489. .

    [doi:10.1016/j.arbr.2021.03.015]

  • Ojanguren A; Santamaría M; Milla-Collado L; Fraile C; Gatius-Calderó S; Puy S; Boldó A; Gómez-Olles S; Boada-Pérez M; Esquinas C; Sáez-Giménez B; Ojanguren I; Barrecheguren M; Olsina-Kissler JJ

    Pilot Trial of Extended Hypothermic Lung Preservation to Analyze Ischemia-reperfusion Injury in Pigs.

    ARCHIVOS DE BRONCONEUMOLOGIA 57 479-489. .

    [doi:10.1016/j.arbres.2021.03.008]

  • Da Cruz Paula A; da Silva, EM; Segura, SE; Pareja, F; Bi, R; Selenica, P; Kim, SH; Ferrando, L; Vahdatinia, M; Soslow, RA; Vidal, A; Gatius, S; Przybycin, CG; Abu-Rustum, NR; Matias-Guiu, X; Rubin, BP; Reis, JS; DeLair, DF; Weigelt, B

    Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary.

    Modern Pathology 33 1606-1617. .

    [doi:10.1038/s41379-020-0514-3]

  • Mayo-de-las-Casas, C; Velasco, A; Sanchez, D; Martínez-Bueno A; Garzón-Ibáñez M; Gatius, S; Ruiz-Mir?, M; Gonzalez-Tallada, X; Llordella, I; Tresserra, F; Rodríguez S; Aldeguer, E; Roman-Canal, B; Bertran-Alamillo, J; García-Peláez B; Rosell, R; Molina-Vila, MA; Matias-Guiu, X

    Detection of somatic mutations in peritoneal lavages and plasma of endometrial cancer patients: a proof-of-concept study.

    INTERNATIONAL JOURNAL OF CANCER 147 277-284. .

    [doi:10.1002/ijc.32872]

  • Moreno, S; Maiques, O; Gatius, S; Vea, A; Barrera, J; Barcelo, C; Santacana, M; Soria, X; Matias-Guiu, X; Marti, RM

    Descriptive study of naevus involution in a series of 74 patients with atypical naevus syndrome under SIAscopy digital follow-up

    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 34 1210-1217. .

    [doi:10.1111/jdv.16084]

Projectes

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • Clinical and functional identification of metastatic colonization biomarkers.
  • Papel de ARID1A en la carcinogénesis endometrial dependiente de contexto. Análisis de los mecanismos moleculares y posibles implicaciones terapéuticas
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • IMPLEMENTATION OF PERSONALIZE MEDICINE IN CUTANEOUS MELANOMA BASED ON GENOMIC SUSCEPTIBILITY AND TUMOR SIGNATURES: IDENTIFICATION OF NEW TARGETS FOR MELANOMA TREATMENT
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
  • Estudio metabolómico del carcinoma de endometrio en relación a parametros morfológicos y moleculares